Ron Cohen, President and CEO at ACORDA THERAPEUTICS INC (ACOR), sold 40,172 shares at $20.75 ($834K) on 2016-12-14, disclosed to the SEC on 2016-12-16.
Seasonal sale ($834k) by President and CEO — this insider has traded ACOR in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.75 | 39,764 | $825K | 99.0% |
| 2 | $21.35 | 408 | $9K | 1.0% |
| Total | $20.76 avg | 40,172 | $834K | 100% |
| Filing → |
| ACOR | SELL | 2019-12-04 | $8K | — | Filing → |
| ACOR | SELL | 2018-12-06 | $75K | — | Filing → |
| ACOR | BUY | 2017-06-20 | $339K | — | Filing → |